Myoview 30 mL - (1.38 mg/vial ; Intravenous Injection)

Generic Name	Technetium TC-99M Tetrofosmin Kit	Innovator	GE Healthcare
Dosage	1.38 mg/vial ; Intravenous Injection	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	MYOVIEW is a kit for the preparation of technetium Tc99m tetrofosmin for injection. Technetium Tc99m tetrofosmin injection is a radioactive diagnostic agent indicated for the following: * Myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease, * Assessment of left ventricular function (left ventricular ejection fraction and wall motion) in patients with known or suspected heart disease.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*********	*** / *********	*** **, ****	*******	****	******* *** **** *** *** ****

Chronology Of Events